Page last updated: 2024-11-02

orphenadrine and Temporomandibular Joint Disorders

orphenadrine has been researched along with Temporomandibular Joint Disorders in 1 studies

Orphenadrine: A muscarinic antagonist used to treat drug-induced parkinsonism and to relieve pain from muscle spasm.
orphenadrine : A tertiary amino compound which is the phenyl-o-tolylmethyl ether of 2-(dimethylamino)ethanol.

Temporomandibular Joint Disorders: A variety of conditions affecting the anatomic and functional characteristics of the temporomandibular joint. Factors contributing to the complexity of temporomandibular diseases are its relation to dentition and mastication and the symptomatic effects in other areas which account for referred pain to the joint and the difficulties in applying traditional diagnostic procedures to temporomandibular joint pathology where tissue is rarely obtained and x-rays are often inadequate or nonspecific. Common diseases are developmental abnormalities, trauma, subluxation, luxation, arthritis, and neoplasia. (From Thoma's Oral Pathology, 6th ed, pp577-600)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rizzatti-Barbosa, CM1
Martinelli, DA1
Ambrosano, GM1
de Albergaria-Barbosa, JR1

Trials

1 trial available for orphenadrine and Temporomandibular Joint Disorders

ArticleYear
Therapeutic response of benzodiazepine, orphenadrine citrate and occlusal splint association in TMD pain.
    Cranio : the journal of craniomandibular practice, 2003, Volume: 21, Issue:2

    Topics: Adult; Anti-Anxiety Agents; Anti-Inflammatory Agents, Non-Steroidal; Benzodiazepines; Clinical Proto

2003